Basis: Current FMP quote-based enterprise value / matching reported total assets. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Assets ratio is N/A as of 2026-10-06T17:57:24.005Z.
Calculation as of: 2026-10-06T17:57:24.005Z.
Quote observation: 2026-10-05T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/ASSETS RATIO
N/A
Market Cap
$559.50M
EV/Assets Ratio
1.44x
TTM Avg
3.28x
3Y Avg
1.55x
5Y Avg
1.16x
Market Cap
$572.98M
EV/Assets Ratio
4.04x
TTM Avg
3.88x
3Y Avg
3.25x
5Y Avg
2.76x
Market Cap
$538.62M
EV/Assets Ratio
2.17x
TTM Avg
4.11x
3Y Avg
2.21x
5Y Avg
1.48x
Market Cap
$536.98M
EV/Assets Ratio
23.01x
TTM Avg
9.52x
3Y Avg
6.68x
5Y Avg
7.35x
Market Cap
$530.02M
EV/Assets Ratio
2.84x
TTM Avg
2.77x
3Y Avg
1.31x
5Y Avg
2.02x
Market Cap
$535.43M
EV/Assets Ratio
3.58x
TTM Avg
3.21x
3Y Avg
4.75x
5Y Avg
3.60x
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiniMed Group, Inc. (MMEDV) | $560.00M | N/A | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX)vs › | $559.50M | 1.44x | 3.28x | 1.55x | 1.16x |
| CorMedix Inc. (CRMD)vs › | $567.99M | 0.50x | 1.12x | 3.33x | 2.77x |
| Aquestive Therapeutics, Inc. (AQST)vs › | $572.98M | 4.04x | 3.88x | 3.25x | 2.76x |
| Shattuck Labs, Inc. (STTK)vs › | $538.62M | 2.17x | 4.11x | 2.21x | 1.48x |
| Nuvectis Pharma, Inc. (NVCT)vs › | $536.98M | 23.01x | 9.52x | 6.68x | 7.35x |
| ProKidney Corp. (PROK)vs › | $536.32M | 1.87x | 0.64x | 0.45x | 3.05x |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $530.02M | 2.84x | 2.77x | 1.31x | 2.02x |
| Delcath Systems, Inc. (DCTH)vs › | $535.43M | 3.58x | 3.21x | 4.75x | 3.60x |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $531.17M | 3.70x | N/A | N/A | N/A |
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
